Volume 13, Number 7—July 2007
Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom
||Crude OR||Adjusted OR‡||95% CI|
|N (%)||% Exposed||N||% Exposed|
|Any code||1,981 (100)||61.1||19,779||35.2||2.98||2.61||2.36–2.89|
*Risk for MRSA diagnosed in the community for persons with any number of antimicrobial drug prescriptions (exposed) in the 30–365 days before their index date relative to risk for MRSA for persons with no prescriptions during the same period. Data from 4 different analyses of a matched case-control study of patients listed in the General Practice Research Database, UK, 2000–2004. OR, odds ratio; CI, confidence interval.
†4JP..00, MRSA positive; SP25800, MRSA infection of postoperative wound; ZV02A00, [V]MRSA multiple-resistant Staphylococcus aureus infection carrier.
‡Adjusted for all covariates in Table 1.
- Page created: June 21, 2010
- Page last updated: June 21, 2010
- Page last reviewed: June 21, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)